Aigen Investment Management LP boosted its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 13.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 27,360 shares of the company's stock after purchasing an additional 3,156 shares during the quarter. Cardinal Health comprises about 0.6% of Aigen Investment Management LP's investment portfolio, making the stock its 17th largest holding. Aigen Investment Management LP's holdings in Cardinal Health were worth $3,769,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently added to or reduced their stakes in the company. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Cardinal Health in the 1st quarter valued at approximately $26,000. Bellwether Advisors LLC bought a new stake in Cardinal Health in the fourth quarter valued at approximately $32,000. Tompkins Financial Corp raised its holdings in Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after purchasing an additional 128 shares during the period. Itau Unibanco Holding S.A. acquired a new stake in Cardinal Health in the fourth quarter worth $36,000. Finally, GW&K Investment Management LLC boosted its position in shares of Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after purchasing an additional 144 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms recently commented on CAH. UBS Group upped their price objective on shares of Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a research report on Tuesday, April 29th. Bank of America boosted their target price on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Robert W. Baird increased their price target on Cardinal Health from $156.00 to $170.00 and gave the stock an "outperform" rating in a report on Friday, May 2nd. Wall Street Zen cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Finally, Morgan Stanley boosted their price objective on Cardinal Health from $181.00 to $190.00 and gave the company an "overweight" rating in a research report on Wednesday, July 16th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $158.07.
Check Out Our Latest Stock Analysis on CAH
Cardinal Health Stock Up 2.6%
Shares of CAH opened at $157.44 on Friday. Cardinal Health, Inc. has a twelve month low of $98.07 and a twelve month high of $168.44. The stock has a market capitalization of $37.58 billion, a P/E ratio of 24.56, a P/E/G ratio of 1.56 and a beta of 0.67. The company has a 50 day moving average of $160.05 and a 200-day moving average of $143.86.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.